FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Melanie van Riemsdijk

Research Profile

Chemicals & Drugs

Activities & Behaviors

Disorders

Geographic Areas

Netherlands

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Wim G Goettsch; Myrthe van Herk-Sukel; Donald L van der Peet; Melanie M van Riemsdijk; Ron Herings
In-hospital use of opioids increases rate of coded postoperative paralytic ileus.
Albert L H J Aarnoudse; Ron van Schaik; Jeanne P Dieleman; Mariam Molokhia; Melanie M van Riemsdijk; Robert J Ligthelm; David Overbosch; Ilse P van der Heiden; Bruno H Ch Stricker
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Melanie M van Riemsdijk; Miriam C J M Sturkenboom; Lolke Pepplinkhuizen; Bruno H Ch Stricker
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Melanie van Riemsdijk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Wim G Goettsch; Myrthe van Herk-Sukel; Donald L van der Peet; Melanie M van Riemsdijk; Ron Herings
In-hospital use of opioids increases rate of coded postoperative paralytic ileus.
Pharmacoepidemiology and drug safety 2007;16(6):668-74.
2006: Albert L H J Aarnoudse; Ron van Schaik; Jeanne P Dieleman; Mariam Molokhia; Melanie M van Riemsdijk; Robert J Ligthelm; David Overbosch; Ilse P van der Heiden; Bruno H Ch Stricker
MDR1 gene polymorphisms are associated with neuropsychiatric adverse effects of mefloquine.
Clinical pharmacology and therapeutics 2006;80(4):367-74.
2005: Melanie M van Riemsdijk; Miriam C J M Sturkenboom; Lolke Pepplinkhuizen; Bruno H Ch Stricker
Mefloquine increases the risk of serious psychiatric events during travel abroad: a nationwide case-control study in the Netherlands.
The Journal of clinical psychiatry 2005;66(2):199-204.
2004: Melanie M van Riemsdijk; Miriam C J M Sturkenboom; JM Ditters; Joke H M Tulen; Robert J Ligthelm; David Overbosch; Bruno H Ch Stricker
Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine.
British journal of clinical pharmacology 2004;57(4):506-12.
2003: Melanie M van Riemsdijk; Miriam C J M Sturkenboom; Herbert J Schilthuis; Bruno H Ch Stricker
Utilisation of malaria prophylaxis: the effect of changes in guidelines in The Netherlands, 1993-1998.
Pharmacy world & science : PWS 2003;25(1):21-4.
2002: Melanie M van Riemsdijk; JM Ditters; Miriam C J M Sturkenboom; Joke H M Tulen; Robert J Ligthelm; David Overbosch; Bruno H Ch Stricker
Neuropsychiatric events during prophylactic use of mefloquine before travelling.
European journal of clinical pharmacology 2002;58(6):441-5.
2002: Melanie M van Riemsdijk; Miriam C J M Sturkenboom; JM Ditters; Robert J Ligthelm; David Overbosch; Bruno H Ch Stricker
Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events.
Clinical pharmacology and therapeutics 2002;72(3):294-301.
1997: Melanie M van Riemsdijk; MM van der Klauw; Lolke Pepplinkhuizen; Bruno H Ch Stricker
Spontaneous reports of psychiatric adverse effects to mefloquine in the Netherlands.
British journal of clinical pharmacology 1997;44(1):105-6.
1997: Melanie M van Riemsdijk; MM van der Klauw; J A van Heest; F R Reedeker; Robert J Ligthelm; Ron Herings; Bruno H Ch Stricker
Neuro-psychiatric effects of antimalarials.
European journal of clinical pharmacology 1997;52(1):1-6.
1996: Bruno H Ch Stricker; Melanie M van Riemsdijk; Miriam C J M Sturkenboom; J P Ottervanger
Taste loss to terbinafine: a case-control study of potential risk factors.
British journal of clinical pharmacology 1996;42(3):313-8.
1995: Melanie M van Riemsdijk; Ron Herings; M D Rawlins; Bruno H Ch Stricker
[Reasons to report or not report side effects of drugs to the national monitoring system in the Netherlands].
Nederlands tijdschrift voor geneeskunde 1995;139(45):2306-8.
1994: Melanie M van Riemsdijk; M M van der Klauw; Bruno H Ch Stricker; Ron Herings
[Skin reactions attributed to the use of bromhexine].
Nederlands tijdschrift voor geneeskunde 1994;138(49):2446-8.